REQUEST A DEMO
Total
USD $0.00
Search more companies

Mydeoma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Mydeoma Vagyonkezelo Beteti Tarsasag Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Mydeoma Bt. is an enterprise in Hungary, with the main office in Budapest. The company operates in the Pharmacies and Drug Stores sector. Mydeoma Bt. was incorporated on October 15, 1996. The total number of employees is currently 10 (2024). In 2023, the company reported a net sales revenue increase of 14.74%. Its’ total assets recorded a growth of 19.45%. Mydeoma Bt.’s net profit margin decreased by 0.19% in 2023.

Headquarters
Szpahi utca 1-9. C. ep. 2. em. 5. ajto
Budapest; Budapest; Postal Code: 1022

Contact Details: Purchase the Mydeoma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Mydeoma Bt. report to view the information.
Outstanding Shares:
Purchase the Mydeoma Bt. report to view the information.
Registered Capital:
Purchase the Mydeoma Bt. report to view the information.
Financial Auditors:
Purchase the Mydeoma Bt. report to view the information.
Incorporation Date:
October 15, 1996
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Mydeoma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
14.74%
Total operating revenue
15.83%
Operating profit (EBIT)
19.13%
EBITDA
15.6%
Net Profit (Loss) for the Period
12.82%
Total assets
19.45%
Total equity
18.59%
Operating Profit Margin (ROS)
0.45%
Net Profit Margin
-0.19%
Return on Equity (ROE)
-1.1%
Quick Ratio
-11.1%
Cash Ratio
-5.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?